antibacterials (Wyeth-Ayerst)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameantibacterials (Wyeth-Ayerst)
Drug Alias NameLL-23-G-277-alphaLL-23-G-277-beta
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Pharmaceuticals Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Pharmaceuticals Co
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A